Resistance Management Strategy for
Group 1 Methyl Benzimidazole Carbamates;
Group 2 dicarboximide;
Group 3 + 11 Demethylaion Inhibitor (DMI) + Quinone outside Inhibitor (QoI);
*Group 7 Succinate dehydrongenase inhibitors (SDHI);
Group 7 + 3 SDHI + DMI;
Group M3 dithiocarbamate; and
*Group M4 Phthalimide.
*Note currently only available under temporary permit. Always check that permits are valid prior to use.
Content last updated: June 10, 2020